A comparative study on 2-(2-benzylidenehydrazinyl)-4-(3-methyl-3-phenylcyclobutyl) thiazole : X-ray, HF and DFT studies
Öz
The title compound, 2-(2-benzylidenehydrazinyl)-4-(3-methyl-3-phenylcyclobutyl)thiazole (C21H21N3S) was prepared and characterized by X – ray single crystal diffraction and IR and NMR spectroscopies. The compound crystallizes in the triclinic space group P with a = 5.8973(4) Å, b = 10.4727(18) Å, c = 15.136(2) Å , α = 86.505(13)˚, β = 84.242(12)˚, γ = 89.870(13)˚ and Z = 2. The molecular geometry was optimized using Hartree-Fock and Density Functional Theory (DFT) (B3LYP) method with the 6-31G(d) basis set. Molecular electrostatic potentiel (MEP) and frontier molecular orbitals (FMO) were executed by the HF/6-31G(d) method.
Kaynakça
- Dehmlow EV, Schmidt S. Synthesis of Stereoisomeric 3-Substituted cyclobutanecarboxylic acid- derivatives. Liebigs Ann Chem 1990; 5: 411–414.
- Coghi L, Lanfredi AMM, Tiripicchio A. Crystal and molecular structure of thiosemicarbazide hydrochloride. J Chem Soc Perkin Trans 1976; 2: 1808-1810.
- Edward LR, Mladenova G. Enantiomerically Pure Cyclobutane Derivatives and Their Use in Organic Synthesis. Chem Rev 2003; 103: 1449–1484.
- Namyslo JC, Kaufmann DE. The application of cyclobutane derivatives in organic synthesis. Chem Rev 2003; 103: 1485–1537.
- Barone R, Chanon M, Gallo R. Aminothiazoles and Their Derivatives: The Chemistry of Heterocyclic Compounds. Interscience Publishers, Wiley, New York, 1979; 34: 9-366.
- Lesyk R, Vladzimirska O, Holota S, Zaprutko L, Gzella A. New 5-substituted thiazolo[3,2- b][1,2,4]triazol-6-ones: Synthesis and anticancer evaluation. Eur J Med Chem 2007; 42: 641–648.
- Lesyk R, Zimenkovsky B, Atamanyuk D, Jensen F, Kiec-Kononowicz K, Gzella A.Anticancer thiopyrano[2,3-d][1,3]thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico- chemical properties, and computational studies. Bioorg Med Chem 2006; 14: 5230–5240.
- Siddiqui N, Ahsan W. Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening. Eur J Med Chem 2010; 45: 1536–1543.
- Satoh A, Nagatomi Y, Hirata Y, Ito S, Suzuki G, Kimura T, Maehara S, Hikichi H, Satow A, Hata M, Ohta H, Kawamoto H. Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6- (isopropylamino) pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist. Bioorg Med Chem Lett 2009; 19: 5464–5468.
- Abdel-Wahab BF, Abdel-Aziz HA, Ahmad EM. Synthesis and antimicrobial evaluation of 1- (benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)- 1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem 2009; 44: 2632–2635.